维普期刊资源整合服务平台（V6.5）

45篇 您的检索式：作者名="Neal JW"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Roles of the complement system inhuman neurodegenerative disorders:pro-inflammatory and tissue remodelingactivities显示文摘	Casque P Neal JW Singhrao SK	2002	Mol Neurobiol2002，25，1：	1
2	First-line use of EGFR tyrosine kinase inhibitors in patients with NSCLC containing EGFR mutations显示文摘	Neal JW Sequist LV	2010	Clin Adv He- matol Oncol2010，8，2：	1
3	Biomechanieal compari- son of 3 possible fixation strategies to resist femoral neckshort- ening after fracture显示文摘	Alves T Neal JW Weinhold PS	2013	Orthopedics2013，16，4：	1
4	First-line treatment of egfr-mutant non-small- cell lung cancer: the role of erlotinib and other tyrosine kinase inhibi- tots显示文摘	Nguyen KS Neal JW	2012	Biologics2012，6，：	1
5	Histology matters: individualizing treatment in non- small cell lung cancer显示文摘	Neal JW	2010	Oneologist2010，15，1：	1
6	Cetuximab monotherapy in patients with advanced non-small cell lung cancer after prior epidermal growth factor receptor tyrosine kinase inhibitor therapy显示文摘	Neal JW Heist RS Fidias P		0，，11：	1
7	Subacute manganese exposure in rats is a neurochemical model of early manganese toxicity显示文摘	O' Neal SL Lee JW Zheng W	2014	Neurotoxicology2014，44，：	1
8	The SELECT study:a multicenter phase Ⅱ trial of adjuvant erlotinib in resected epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC)显示文摘	Neal JW Pennell NA Govindan R		0，，：	1
9	The SELECT study: A multicenter phase 1I trial of adjuvant erlotinib in resected epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC)显示文摘	Neal JW Pennell NA Govindan R	2012	J Clin Oncol2012，30，15：	1
10	SELECT: A multicenter phase 1I trial of adjuvant erlotinib in resected early-stage EGFR mutation-positive NSCLC显示文摘	Pennell NA Neal JW Chaft JE	2014	J Clin Oncol2014，32，15：	1
11	Innate immunity and protective neuroinflammation:new emphasis on the role of neuroimmune regulatory proteins显示文摘	Griffiths M Neal JW Gasque P		0，，82：	1
12	First-linetreatment of EGFR-mutant non- small-cell lung cancer: the role of erlotinib and other tyrosine ki- nase inhibitors显示文摘	Nguyen KS Neal JW	2012	Biologies2012，6，：	1
13	Current management of small cell lung cancer显示文摘	Neal JW Gubens MA Wakelee HA	2011	Clin Chest Med2011，，32：	1
14	Encephalitis due to emerging viruses:CNS innate immunity and potential therapeutic targets显示文摘	Denizot M Neal JW Gasque P	2012	7 Infect2012，65，1：	1
15	Biomechanical comparison of 3 possible fixation strategies to resist femoral neck shortening after fracture显示文摘	Aives T Neal JW Weinhold PS		0，，：	1
16	The SELECT study:A multicenter phase II trial of adjuvant erlotinib in resected epidermal growth factor receptor(EGFR)mutation-positive non-small cell lung cancer(NSCLC)显示文摘	Neal JW Pennell NA Govindan R	2012	J Clin Oncol2012，30，15：	1
17	Postprandial serum glucose, insulin, and lipoprotein responses to high- and low-fiber diets显示文摘	Anderson JW O'Neal Spencer DS Riddell Mason S	1995	Metabolism1995，44，7：	1
18	A multicenter phase II trial of adjuvant Erlotinib in resected early-stage EGFR mutation-positive NSCLC显示文摘	Pennell NA Neal JW Chaft JE	2014	J Clin Oncol2014，32，5：	1
19	Biomechanical comparison of 3possible fixation strategies to resist femoral neck shortening after fracture显示文摘	Alves T Neal JW Weinhold PS	2010	Orthopedics2010，16，2：	1
20	A multicenter phase II trial of adjuvant erlotinib in patients with resected non-small cell lung cancer(NSCLC)and mutations in the epidermal growth factor receptor(EGFR):Toxicity evaluation显示文摘	Neal JW Pennell NA Goodgame BW	2010	J Clin Oncol2010，28，15：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示